Re: UCB - BEL20

Quebra de LTD MP. Bull nos restantes horizontes temporais.
Fórum dedicado à discussão sobre os Mercados Financeiros - Bolsas de Valores
http://caldeiraodebolsa.jornaldenegocios.pt/
http://caldeiraodebolsa.jornaldenegocios.pt/viewtopic.php?f=3&t=81725
Sector
Healthcare
Biotechnology / Pharmaceuticals
Biotechnology / Pharmaceuticals
Pharmaceuticals - Diversified
Business Summary
UCB is a biopharmaceutical company focused on the discovery and the development of innovative medicines in the fields of central nervous system and immunology disorders. Net sales break down by activity as follows:
- sales of bio-pharmaceutical products (88.6%): for treating central nervous system disorders (47% of net sales; epilepsy, hyperactivity, cognitive disorders, etc.), immune disorders and allergies (24%) and other (29%);
- sales of licences (5.8%);
- other (5.6%).
fonte: 4-traders.com